55
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Influential factors on radiotherapy efficacy and prognosis in patients with secondary lymph node metastasis after esophagectomy of thoracic esophageal squamous cell carcinoma

, , &
Pages 217-225 | Published online: 02 Feb 2018

References

  • LiuQCaiXWWuBZhuZFChenHQFuXLPatterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapyPLoS One201495e9722524820177
  • NakagawaSKandaTKosugiSOhashiMSuzukiTHatakeyamaKRecurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomyJ Am Coll Surg2004198220521114759776
  • ChenGWangZLiuXYLiuFYRecurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomyWorld J Surg20073151107111417426905
  • ChenYZhangZJiangGZhaoKGross tumor volume is the prognostic factor for squamous cell esophageal cancer patients treated with definitive radiotherapyJ Thorac Dis2016861155116127293832
  • HolgerssonGSandelinMHoyeESwedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancerMed Oncol20122953176318222565809
  • NjolstadTSEngerudHWernerHMSalvesenHBTrovikJPreoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomasGynecol Oncol2013131241041524004646
  • RoxburghCSMcMillanDCRole of systemic inflammatory response in predicting survival in patients with primary operable cancerFuture Oncol20106114916320021215
  • RassouliASalibaJCastanoRHierMZeitouniAGSystemic inflammatory markers as independent prognosticaters of head and neck squamous cell carcinomaHead Neck201537110311024339165
  • KozakMMvon EybenRPaiJSThe prognostic significance of pretreatment hematologic parameters in patients undergoing resection for colorectal cancerAm J Clin Oncol201740440541225756348
  • YodyingHMatsudaAMiyashitaMPrognostic signifcance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysisAnn Surg Oncol201623264665426416715
  • AbsengerGSzkanderaJPichlerMA derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patientsBr J Cancer2013109239540023820252
  • KohCHBhoo-PathyNNgKLUtility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancerBr J Cancer2015113115015826022929
  • XuAMHuangLZhuLWeiZJSignificance of peripheral neutrophil-lymphocyte ratio among gastric cancer patients and construction of a treatment-predictive model: a study based on 1131 casesAm J Cancer Res20144218919524660108
  • CannonNAMeyerJIyengarPNeutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancerJ Thorac Oncol201510228028525299234
  • FanWZhangYWangYYaoXYangJLiJNeutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolizationPLoS One2015103e011931225742141
  • XieXLuoKJHuYWangJYChenJPrognostic value of preoperative platelet–lymphocyte and neutrophil–lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancerDis Esophagus2016291798525410116
  • FengJFHuangYChenQXPreoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinomaWorld J Surg Oncol2014125824641770
  • EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1)Eur J Cancer200945222824719097774
  • HöckelMSchlengerKMitzeMSchäfferUVaupelPHypoxia and radiation response in human tumorsSemin Radiat Oncol1996613910717157
  • BalkwillFMantovaniAInflammation and cancer: back to VirchowLancet2001357925553954511229684
  • KijimaTArigamiTUchikadoYCombined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinomaCancer Sci2017108219319927889946
  • ZhuSMiaoCWWangZTPengLLiBWSensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinomaOnco Targets Ther201696187619327789959
  • DuanHZhangXWangFXPrognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinomaWorld J Gastroenterol201521185591559725987784
  • NowarskiRGaglianiNHuberSFlavellRAInnate immune cells in inflammation and cancerCancer Immunol Res201312778424777498
  • HonnKVTangDGCrissmanJDPlatelets and cancer metastasis: a causal relationship?Cancer Metastasis Rev1992113–43253511423821
  • Salazar-OnfrayFLopezMNMendoza-NaranjoAParadoxical effects of cytokines in tumor immune surveillance and tumor immune escapeCytokine Growth Factor Rev2007181–217118217329145
  • ThurnerEMKrenn–PilkoSLangsenlehnerUThe elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapyEur J Cancer201551561061925618827
  • SzkanderaJStotzMAbsengerGValidation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patientsBr J Cancer2014110118318824201751